Make $ With These 5 Blue Chips
|Written by GSCR Staff|
|Wednesday, 22 May 2013 07:53|
We rarely mention blue chip stocks in these pages but sometimes you gotta do what you gotta do. For those market watchers that are concerned about any modest decline in the stock market having a more pronounced effect on small cap stocks, one should consider some of the bluest of the blue chips. Below are 5 diverse stocks from the DJIA that each carry a dividend yield greater than 3% and trade below $80 per share and below the 15x P/E multiple on FY13 EPS estimates, which is considered the average forward multiple on blue chip stocks and the S&P 500 Index.
With the 10-year bond yield hovering around 2%, it is a bit surprising that some of the world’s biggest and best known companies still trade at reasonable P/E multiples and offer a dividend that is at least 50% greater than the bond yield, especially considering the market rise. With that said, step right up and diversify away.
Proctor and Gamble (NYSE - PG - $78.80):
PG has an annual dividend of $2.41yielding 3.06%. This is a phenomenal play on a diverse company with a focus on consumer staples. As any broker or advisor would state, “No matter how bad the economy gets people are still going to shower.”
Intel (NASDAQ – INTC – $24.15):
Intel is the bellwether for the computer chip industry and one of the old-line technology stocks that seems to have been overshadowed by other tech stocks due to their heavy exposure to the underwhelming computer space. INTC has a current dividend yield of 3.73% paying out $0.90 per year and carries a 12.8x P/E on FY13 EPS estimates.
Pfizer (NYSE – PFE - $28.78):
PFE looks undervalued from both from a dividend yield and P/E perspective compared the other major players in the mega-cap pharmaceutical space. The annual dividend is currently at $0.96 yielding 3.34% and has a FY13 P/E of 13.1.
AT & T (NYSE – T - $36.94):
‘Ma Bell’ is still around and kicking with a dividend yield of 4.87% and $1.80 annual payout. While there may be better growth options in telecom, this stock is stable and the company has expanded its products and offerings by adding more income sources. Its P/E is a reasonable 14.7x.
General Electric (NYSE- GE – $23.66):
A lot of active traders and growth investors do not like the GE as one prevailing sentiment is that the company is ‘over-diversified’. The criticism may be fair but the company’s multi-sector strategy makes the stock attractive from a low volatility and income generating perspective. GE is currently paying out $0.76 annually yielding 3.21% and has a 14.5x P/E multiple on FY13 EPS.
Have a great day.
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com
Leave your comments